Spitzer, Barbara

Publications

Sort by

Co-Author Network

selected publications

ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML. Blood advances. 2021 Academic Article GET IT
Times cited: 4
Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms. Clinical cancer research : an official journal of the American Association for Cancer Research. 2021 Academic Article GET IT
Times cited: 8
CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation. Blood. 2021 Academic Article GET IT
Times cited: 16
Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis. Nature communications. 2021 Academic Article GET IT
Times cited: 37
Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nature genetics. 2020 Academic Article GET IT
Times cited: 221
Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation. Cytotherapy. 2020 Academic Article GET IT
Times cited: 20
Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant. Bone marrow transplantation. 2020 Academic Article GET IT
Times cited: 10
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation. The Journal of clinical investigation. 2020 Academic Article GET IT
Times cited: 111
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL. Blood. 2019 Academic Article GET IT
Times cited: 140
JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition. The Journal of clinical investigation. 2018 Academic Article GET IT
Times cited: 5
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. Cancer discovery. 2018 Academic Article GET IT
Times cited: 47
JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition. The Journal of clinical investigation. 2018 Academic Article GET IT
Times cited: 56
A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 4
Acid ceramidase is upregulated in AML and represents a novel therapeutic target. Oncotarget. 2016 Academic Article GET IT
Times cited: 61
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling. Nature medicine. 2016 Academic Article GET IT
Times cited: 169
Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status". Nature medicine. 2016 Letter GET IT
Times cited: 7
Second Allogeneic Stem Cell Transplantation for Acute Leukemia Using a Chemotherapy-Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 7
Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. Nature. 2016 Academic Article GET IT
Times cited: 156
Cutaneous involvement of disseminated adenovirus infection in an allogeneic stem cell transplant recipient. 2016 GET IT
Times cited: 12
Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells. Leukemia. 2015 Academic Article GET IT
Times cited: 53
Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis. The Journal of experimental medicine. 2015 Academic Article GET IT
Times cited: 112
Loss of BAP1 function leads to EZH2-dependent transformation. Nature medicine. 2015 Academic Article GET IT
Times cited: 253
CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms. Cancer cell. 2015 Academic Article GET IT
Times cited: 110
Late complications of mixed chimerism following allogeneic bone marrow transplantation for thalassemia major. Pediatric blood & cancer. 2015 Letter GET IT
Times cited: 5
Therapeutic Re-Activation of Protein Phosphatase 2A in Acute Myeloid Leukemia. Frontiers in oncology. 2015 Review GET IT
Times cited: 75
Genetic alterations of the cohesin complex genes in myeloid malignancies. Blood. 2014 Academic Article GET IT
Times cited: 167
Posttransplant lymphoproliferative disorder complicating hematopoietic stem cell transplantation in a patient with dyskeratosis congenita. 2012 GET IT
Times cited: 9

more ...

less ...

Background

education and training

M.D., New York University School of Medicine 2008
B.A., Columbia University 2004

Contact

full name

Barbara Spitzer

VIVO Weill Cornell Medical College

Barbara Spitzer Assistant Professor of Pediatrics

Publications

selected publications

Background

education and training

Contact

full name